General characteristics and pharmacological properties
The drug we are studying belongs to the group of synthetic immunomodulators. Its active substance is sodium aminodihydrophthalazinedione. Being a synthetic compound, it has a precisely verified chemical structure, which ensures the realization of its pharmacological effects in the patient's body.
In clinical pharmacology, there are three key properties of this medication that determine its value in medical practice. First, it has a pronounced immunomodulatory effect—the ability of the drug to purposefully influence the functioning of the body's defense systems. Second, the drug demonstrates antioxidant activity, which is an important factor in the treatment of various pathologies. Third, the agent has an anti-inflammatory effect. The combination of these three pharmacological properties—immunomodulatory, antioxidant, and anti-inflammatory—makes the drug an important component in the treatment of infectious diseases.
Mechanism of action: from macrophages to interferons
To understand how sodium aminodihydrophthalazinedione works, it is necessary to examine its mechanism of action in detail. The main site of action of the drug is the monocyte-macrophage system. The drug specifically affects these cells of the immune system, altering their functional activity.
One of the most important manifestations of this effect is its impact on the process of phagocytosis. The drug actively stimulates the bactericidal activity of neutrophils. A pharmacological feature of this agent is that this stimulating effect is most pronounced when the patient has an initial deficiency in the function of these cells. Under the influence of the drug, neutrophils begin to perform phagocytosis much more efficiently, destroying pathogenic microorganisms.
In addition to influencing cellular phagocytosis, the drug actively intervenes in the synthesis of defense factors. Under its influence, the production of antibodies reliably increases. Concurrently, the production of interferons (IFN) increases. Thus, the drug works comprehensively, stimulating both cellular mechanisms (neutrophils and macrophages) and the production of protective proteins (antibodies and interferons).
Application features and contraindications
The key clinical effect for which the drug is prescribed is an increase in nonspecific resistance to infections. In study materials and test questions, it is often required to choose what exactly the drug affects: specific, cellular, humoral immunity, or nonspecific resistance. The correct answer is precisely the increase in the body's nonspecific resistance.
Students must firmly learn the most important rule of application: this immunomodulator is not used on its own. Its use as a single method of treatment is unacceptable. The drug is used exclusively as part of complex therapy in the treatment of bacterial and viral infections. It acts as a component that complements the main treatment.
Like any pharmacological agent, the drug has strict prescribing limitations. The contraindications list clearly indicates two conditions. First is pregnancy. Second, the use of the drug is strictly contraindicated during the lactation period. Prescribing the agent to female patients during these periods is strictly prohibited.
Briefly: answers to topical questions
What are the contraindications for the use of Galavit?
Contraindications to the use of Galavit are pregnancy and lactation.
In which specific nosologies is the prescription of Galavit indicated as part of complex therapy?
Specific nosological forms are not indicated in the available materials. Galavit is used only as part of complex therapy for bacterial and viral infections; it is not used as a monotherapy.
For quick memorization, use the "Three A's" rule: Aminodihydrophthalazinedione (substance), Antioxidant (property), Antibodies (increases synthesis). And the main target is MMM (Monocyte-Macrophage Target).
Class and exam questions
Can a viral infection be treated with this drug alone?
No, this is unacceptable. The drug is not used on its own; its use is justified only as part of complex therapy for viral and bacterial infections.
What is the main site of action of the drug in the immune system?
The main target is the monocyte-macrophage system. By acting on it, the drug stimulates phagocytosis and the bactericidal activity of neutrophils.
In which cases is the drug's stimulation of neutrophils most pronounced?
The pharmacological effect on neutrophils is especially pronounced if the patient has an initial deficiency in their bactericidal activity.
How does the drug affect the production of protective factors?
It increases antibody synthesis and stimulates the production of interferons (IFN), which contributes to increased nonspecific resistance.
What else to study on this topic
- Structure and functions of the monocyte-macrophage system of immunity.
- Mechanisms of phagocytosis and assessment of the bactericidal activity of neutrophils.
- The process of antibody synthesis and the role of interferons (IFN) in body defense.
- Differences between nonspecific resistance and specific immunity.
- Principles of forming complex therapy for bacterial and viral infections.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on the topic "Galavit" and another 5,304 pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Regulating Immune Processes"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.